Whitefort Capital Management, LP

In its 13F for Q1 2025 (holdings as of March 31, 2025, filed May 15, 2025), Whitefort Capital Management, LP reported 11 stock positions worth $185.2 million. Its top holding was Arbutus Biopharma (ABUS) at 25.1% of the portfolio, followed by Roivant Sciences (ROIV, 18.6%) and Joyy Inc.-ADR (JOYY, 17.2%). Compared with Q4 2024, it opened 1 new position, sold out of 3, added to 4 and reduced 1. The biggest buy was Joyy Inc.-ADR (JOYY, shares +81%) and the biggest sale an exit from Endeavor Group Hold Class A (EDR).

Most Recent 13F
Q2 2026
Location
NEW YORK, NY
CIK
0001884931
Portfolio Value
$185.2M (Q1 2025)
SEC Filing
0001013594-25-000674 ↗ filed May 15, 2025

Holdings Value

0$100.0M$200.0M$300.0M$400.0M Q1 2024: $153.2M Q1 2024 Q2 2024: $143.4M Q2 2024 Q3 2024: $201.5M Q3 2024 Q4 2024: $191.5M Q4 2024 Q1 2025: $185.2M $185.2M Q1 2025 Q2 2025: $239.0M Q2 2025 Q3 2025: $287.4M Q3 2025 Q4 2025: $317.7M Q4 2025 Q1 2026: $316.6M Q1 2026 Q2 2026: $391.6M Q2 2026

Holdings 11 stocks · $185.2M
ABUS Arbutus Biopharma Corp. 25.08% 13,307,967 $46.4M Add +0.5%
ROIV Roivant Sciences Ltd. 18.59% 3,411,000 $34.4M Add +42.7%
JOYY Joyy Inc.-ADR 17.22% 759,443 $31.9M Add +80.6%
GNW Genworth Financial Inc. 11.44% 2,986,960 $21.2M No change
LQDA Liquidia Corp. 8.37% 1,050,180 $15.5M Reduce -47.1%
CDZI Cadiz Inc. 5.89% 3,719,951 $10.9M No change
OABI Omniab Inc. 5.07% 3,914,896 $9.4M New
GSL Global Ship Lease Inc. Class A 4.56% 369,768 $8.4M No change
VATE Innovate Corp. 3.14% 743,000 $5.8M Add +132.1%
MHLD Maiden Holdings Ltd. 0.62% 1,997,005 $1.1M No change
TRINITY BIOTECH INVT LTD 0.03% 81,902 $47K No change
Other holdings (4): bonds, preferreds, convertibles and warrants · $27.4M (not counted above)
SecurityClassShares / PrincipalValueChange
OPKO HEALTH INC (OPK 3.75 01/15/29) NOTE 3.750% 1/1 · principal 9,350,000$15.1MNew
INNOVATE CORP (VATE 7.5 08/01/26 *) NOTE 7.500% 8/0 · principal 12,218,000$7.1MNo change
SABRE GLBL INC (SABHLD 4 04/15/25) NOTE 4.000% 4/1 · principal 5,000,000$5.0MNo change
NNAVW Nextnav Inc. *W EXP 99/99/999 47,264$208KReduce -53.1%

Total filed on the 13F, all lines: $212.5M.

Portfolio Sells Q4 2024 → Q1 2025
EDR Endeavor Group Hold Class A Sold out 0.00% −8.17
NN Nextnav Inc. Sold out 0.00% −5.12
LQDA Liquidia Corp. Reduce -47.1% 8.37% −3.84
OPK Opko Health Inc. Sold out 0.00% −0.10

Portfolio Buys Q4 2024 → Q1 2025
JOYY Joyy Inc.-ADR Add +80.6% 17.22% +8.03
OABI Omniab Inc. New 5.07% +5.07
ROIV Roivant Sciences Ltd. Add +42.7% 18.59% +3.82
ABUS Arbutus Biopharma Corp. Add +0.5% 25.08% +2.47
VATE Innovate Corp. Add +132.1% 3.14% +2.32

Notes & Other Activity Q4 2024 → Q1 2025
OPKO HEALTH INC (OPK 3.75 01/15/29) NOTE 3.750% 1/1 · principal New 9,350,000 $15.1M
ESPERION THERAPEUTICS (ESPR 4 11/15/25) NOTE 4.000%11/1 · principal Sold out 8,000,000 $7.8Mbefore exit
NNAVW Nextnav Inc. *W EXP 99/99/999 Reduce -53.1% 47,264 $208K
AEAEW Altenergy Acquisition -CW23 *W EXP 10/29/202 Sold out 186,315 $783before exit

Bonds, preferreds, convertibles and warrants; not part of the stock holdings or percentages above.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 18$391.6MABUS, ROIV, JOYY, BALY, GNW
Q1 2026 17$316.6MABUS, ROIV, JOYY, SOC, GNW
Q4 2025 15$317.7MABUS, ROIV, BALY, OABI, JOYY
Q3 2025 14$287.4MABUS, ROIV, GNW, JOYY, OABI
Q2 2025Amended 14$239.0MJOYY, ROIV, ABUS, GNW, OABI
Q1 2025 11$185.2MABUS, ROIV, JOYY, GNW, LQDA
Q4 2024 13$191.5MABUS, ROIV, LQDA, GNW, CDZI
Q3 2024 13$201.5MABUS, EDR, ROIV, JOYY, GNW
Q2 2024 16$143.4MABUS, ROIV, NN, GNW, GSL
Q1 2024 13$153.2MGSL, ABUS, ROIV, LSXMK, GNW